Blue Owl Capital Holdings LP
In its 13F for Q4 2025 (holdings as of December 31, 2025, filed February 20, 2026), Blue Owl Capital Holdings LP reported 50 stock positions worth $320.9 million. Its top holding was Engene (ENGN) at 9.5% of the portfolio, followed by Nuveen Churchill Direct Lend (NCDL, 8.9%) and Blue Owl Capital (OBDC, 8.1%). Compared with Q3 2025, it opened 12 new positions, sold out of 8, added to 13 and reduced 12. The biggest buy was Compass Therapeutics (CMPX, shares +34%) and the biggest sale an exit from Evercommerce (EVCM).
- Most Recent 13F
- Q2 2026
- Location
- New York, NY
- CIK
- 0001858703
- Portfolio Value
- $320.9M (Q4 2025)
- SEC Filing
- 0001193125-26-061298 ↗ filed Feb 20, 2026
Holdings Value
Holdings 50 stocks · $320.9M
| ENGN Engene Holdings Inc. | 9.46% | 3,360,937 | $30.3M | Add +2.5% |
| NCDL Nuveen Churchill Direct Lend | 8.91% | 2,143,626 | $28.6M | Reduce -30.7% |
| OBDC Blue Owl Capital Corp. | 8.14% | 2,045,070 | $26.1M | No change |
| LRMR Larimar Therapeutics Inc. | 8.10% | 6,823,690 | $26.0M | Add +16.6% |
| CGEM Cullinan Therapeutics Inc. | 7.58% | 2,350,972 | $24.3M | Reduce -6.4% |
| CMPX Compass Therapeutics Inc. | 5.80% | 3,466,525 | $18.6M | Add +33.8% |
| HLLY Holley Inc. | 5.34% | 4,146,636 | $17.1M | Reduce -14.7% |
| CNTX Context Therapeutics Inc. | 3.40% | 7,432,906 | $10.9M | Add +0.3% |
| CNDT Conduent Inc. | 2.88% | 4,822,422 | $9.3M | Add +8.2% |
| RPTX Repare Therapeutics Inc. | 2.79% | 3,443,659 | $9.0M | No change |
| CVEO Civeo Corp. | 2.64% | 370,530 | $8.5M | Add +16.7% |
| SGMT Sagimet Biosciences Inc. Class A | 2.29% | 1,243,877 | $7.4M | Reduce -6.4% |
| EYPT Eyepoint Inc. | 2.23% | 392,594 | $7.2M | Add +6.8% |
| PCOR Procore Technologies Inc. | 2.14% | 94,264 | $6.9M | New |
| DELL Dell Technologies -C | 2.11% | 53,848 | $6.8M | Add +2.9% |
| KALV Kalvista Pharmaceuticals Inc. | 1.81% | 360,000 | $5.8M | Add +188.0% |
| MPLT Maplight Therapeutics Inc. | 1.79% | 327,058 | $5.7M | New |
| ROIV Roivant Sciences Ltd. | 1.78% | 263,249 | $5.7M | Reduce -73.4% |
| IMA Imagenebio Inc. | 1.77% | 823,785 | $5.7M | Add +52.3% |
| IMMX Immix Biopharma Inc. | 1.61% | 986,240 | $5.2M | New |
| RARE Ultragenyx Pharmaceutical Inc. | 1.52% | 212,638 | $4.9M | Reduce -49.7% |
| IMRX Immuneering Corp. Class A | 1.36% | 665,000 | $4.4M | Add +20.9% |
| PVLA Palvella Therapeutics Inc. | 1.31% | 40,259 | $4.2M | Reduce -57.7% |
| ORIC Oric Pharmaceuticals Inc. | 1.31% | 515,000 | $4.2M | New |
| PAYO Payoneer Global Inc. | 1.24% | 832,810 | $4.0M | New |
| PLRX Pliant Therapeutics Inc. | 1.13% | 2,969,199 | $3.6M | No change |
| CNTA Centessa Pharmaceuticals Ltd. | 1.09% | 139,450 | $3.5M | Reduce -17.7% |
| AQST Aquestive Therapeutics Inc. | 1.06% | 525,000 | $3.4M | Reduce -58.0% |
| CMPS Compass Pathways PLC | 1.01% | 469,914 | $3.2M | Reduce -22.3% |
| ADCT Adc Therapeutics SA | 0.91% | 733,568 | $2.9M | No change |
| ELDN Eledon Pharmaceuticals Inc. | 0.91% | 1,929,912 | $2.9M | Add +97.0% |
| NU Nu Holdings Ltd./Cayman Isl-A filed as NU HLDGS LTD | 0.91% | 173,873 | $2.9M | No change |
| LENZ Lenz Therapeutics Inc. | 0.75% | 150,000 | $2.4M | New |
| MLYS Mineralys Therapeutics Inc. | 0.75% | 65,944 | $2.4M | Reduce -34.7% |
| JANX Janux Therapeutics Inc. | 0.43% | 100,000 | $1.4M | New |
| CHYM Chime Financial Inc. Class A | 0.31% | 39,886 | $1.0M | New |
| EPD Enterprise Products Partners | 0.31% | 31,290 | $1.0M | No change |
| FLD Fold Holdings Inc. filed as FOLD HLDGS INC | 0.31% | 856,632 | $985K | No change |
| MRKR Marker Therapeutics Inc. | 0.26% | 554,250 | $826K | No change |
| CAH Cardinal Health Inc. | 0.11% | 1,718 | $353K | No change |
| CID HOLDCO INC | 0.08% | 557,361 | $251K | New |
| OMDA Omada Health Inc. | 0.08% | 15,377 | $243K | New |
| TTAN Servicetitan Inc. Class A | 0.08% | 2,266 | $241K | Reduce -54.3% |
| PIPR Piper Sandler Cos | 0.06% | 607 | $206K | No change |
| ALPHA MODUS HLDGS INC | 0.06% | 394,078 | $181K | No change |
| ENGENE HOLDINGS INC | 0.03% | 36,100 | $103K | No change |
| SHFS SHF Holdings Inc. | 0.03% | 75,897 | $80K | No change |
| AEON Aeon Biopharma Inc. | 0.01% | 43,395 | $48K | Add +2.5% |
| ANGX Angel Studios Inc. | 0.01% | 10,000 | $47K | New |
| BLNE Beeline Holdings Inc. | 0.00% | 129,529 | $0 | New |
Other holdings (30): bonds, preferreds, convertibles and warrants · $3.1M (not counted above)
| Security | Class | Shares / Principal | Value | Change |
|---|---|---|---|---|
| NIOBW Niocorp Developments Ltd. -28 | *W EXP 03/17/202 | 876,148 | $1.7M | Add +60.3% |
| DRTSW Alpha Tau Medical Ltd. -27 | *W EXP 99/99/999 | 1,166,118 | $396K | New |
| RZLVW Rezolve AI PLC -CW27 | *W EXP 08/15/202 | 289,309 | $240K | Reduce -1.2% |
| OPTXW Omnilit Acquisition Class A -23 | *W EXP 99/99/999 | 803,132 | $193K | No change |
| BNAIW Brand Engagement Netwo -CW27 | *W EXP 03/14/202 | 2,726,276 | $109K | Add +63.6% |
| AMODW Insight Acquisition Co. -CW23 | *W EXP 12/13/202 | 1,854,665 | $93K | No change |
| SLND.WS Legato Merger Corp. II -CW23 | *W EXP 02/14/202 | 860,302 | $77K | No change |
| BGLWW Blue Gold Ltd. | *W EXP 04/01/203 | 175,000 | $77K | No change |
| RDZNW Vahanna Tech Edge -CW24 | *W EXP 11/30/202 | 225,000 | $61K | No change |
| LVWR.WS Livewire Group Inc.-27 | *W EXP 09/26/202 | 500,000 | $30K | Add +25.0% |
| DAVEW Dave Inc. -CW27 | *W EXP 01/05/202 | 28,750 | $28K | No change |
| DAICW Cid Holdco Inc. -26 | *W EXP 12/31/202 | 300,000 | $24K | No change |
| BKSYW Blacksky Technology -CW24 | *W EXP 09/09/202 | 350,000 | $18K | No change |
| PGYWW Pagaya Technologies Ltd. -27 | *W EXP 99/99/999 | 48,661 | $16K | No change |
| NVNWF Nvni Group Ltd.-28 | *W EXP 11/01/202 | 200,000 | $14K | No change |
| ZEOWW Esgen Acquisition A -CW23 | *W EXP 03/13/202 | 250,000 | $10K | No change |
| TVGNW Semper Paratus Acqu -CW26 | *W EXP 02/14/202 | 200,000 | $8K | No change |
| BTMWQ Bitcoin Depot Inc.-CW23 | *W EXP 06/30/202 | 50,000 | $6K | No change |
| BAERW Wildfire New Pubco Inc.-27 | *W EXP 01/24/202 | 25,000 | $5K | New |
| BDMDW Baird Medical Investment -28 | *W EXP 10/01/202 | 100,000 | $5K | No change |
| BSLKW Golden Arrow Merger A -CW26 | *W EXP 08/13/202 | 166,666 | $3K | No change |
| SDSTW Global Partner Acq A -CW27 | *W EXP 06/21/202 | 31,666 | $3K | Add +90.0% |
| PDYNW Sarcos Technology -CW27 | *W EXP 09/24/202 | 35,000 | $2K | New |
| LIMNW Liminatus Pharma Inc. Class A-28 | *W EXP 04/30/203 | 50,000 | $2K | No change |
| MLKWF Waldencast Acq Class A -CW27 | *W EXP 07/27/202 | 33,333 | $1K | No change |
| ASBPW Aspire Biopharma Holdin-CW27 | *W EXP 02/14/203 | 50,000 | $1K | No change |
| XBPEW CF Acquisition Viii A -CW27 | *W EXP 11/30/202 | 24,778 | $743 | No change |
| CXAIW Kins Tech Group Class A -CW25 | *W EXP 99/99/999 | 12,500 | $625 | New |
| SLXNW Biomotion Sciences-CW29 | *W EXP 08/15/202 | 12,500 | $375 | New |
| KPLTW Katapult Holdings Inc. -CW26 | *W EXP 06/09/202 | 400,000 | $0 | No change |
Total filed on the 13F, all lines: $324.0M.
Portfolio Sells Q3 2025 → Q4 2025
| EVCM Evercommerce Inc. | Sold out | 0.00% | −5.71 |
| NCDL Nuveen Churchill Direct Lend | Reduce -30.7% | 8.91% | −4.43 |
| ROIV Roivant Sciences Ltd. | Reduce -73.4% | 1.78% | −2.89 |
| RARE Ultragenyx Pharmaceutical Inc. | Reduce -49.7% | 1.52% | −2.45 |
| IRON Disc Medicine Inc. | Sold out | 0.00% | −2.11 |
| KRRO Korro Bio Inc. | Sold out | 0.00% | −1.57 |
| AQST Aquestive Therapeutics Inc. | Reduce -58.0% | 1.06% | −1.13 |
| MREO Mereo Biopharma Group PL-ADR | Sold out | 0.00% | −0.81 |
| ACLX Arcellx Inc. | Sold out | 0.00% | −0.69 |
| SGMT Sagimet Biosciences Inc. Class A | Reduce -6.4% | 2.29% | −0.55 |
| PVLA Palvella Therapeutics Inc. | Reduce -57.7% | 1.31% | −0.55 |
| MLYS Mineralys Therapeutics Inc. | Reduce -34.7% | 0.75% | −0.45 |
| TNGX Tango Therapeutics Inc. | Sold out | 0.00% | −0.31 |
| CNTA Centessa Pharmaceuticals Ltd. | Reduce -17.7% | 1.09% | −0.20 |
| GTLB Gitlab Inc. Class A | Sold out | 0.00% | −0.17 |
| TTAN Servicetitan Inc. Class A | Reduce -54.3% | 0.08% | −0.08 |
| CMPS Compass Pathways PLC | Reduce -22.3% | 1.01% | −0.07 |
| VRNA Verona Pharma Ltd. | Sold out | 0.00% | 0.00 |
| HLLY Holley Inc. | Reduce -14.7% | 5.34% | +0.56 |
| CGEM Cullinan Therapeutics Inc. | Reduce -6.4% | 7.58% | +2.93 |
Portfolio Buys Q3 2025 → Q4 2025
| CMPX Compass Therapeutics Inc. | Add +33.8% | 5.80% | +2.96 |
| ENGN Engene Holdings Inc. | Add +2.5% | 9.46% | +2.46 |
| LRMR Larimar Therapeutics Inc. | Add +16.6% | 8.10% | +2.19 |
| PCOR Procore Technologies Inc. | New | 2.14% | +2.14 |
| MPLT Maplight Therapeutics Inc. | New | 1.79% | +1.79 |
| IMMX Immix Biopharma Inc. | New | 1.61% | +1.61 |
| KALV Kalvista Pharmaceuticals Inc. | Add +188.0% | 1.81% | +1.34 |
| ORIC Oric Pharmaceuticals Inc. | New | 1.31% | +1.31 |
| PAYO Payoneer Global Inc. | New | 1.24% | +1.24 |
| CNTX Context Therapeutics Inc. | Add +0.3% | 3.40% | +1.16 |
| LENZ Lenz Therapeutics Inc. | New | 0.75% | +0.75 |
| EYPT Eyepoint Inc. | Add +6.8% | 2.23% | +0.60 |
| JANX Janux Therapeutics Inc. | New | 0.43% | +0.43 |
| IMA Imagenebio Inc. | Add +52.3% | 1.77% | +0.39 |
| CVEO Civeo Corp. | Add +16.7% | 2.64% | +0.36 |
| CHYM Chime Financial Inc. Class A | New | 0.31% | +0.31 |
| IMRX Immuneering Corp. Class A | Add +20.9% | 1.36% | +0.16 |
| ELDN Eledon Pharmaceuticals Inc. | Add +97.0% | 0.91% | +0.11 |
| CID HOLDCO INC | New | 0.08% | +0.08 |
| OMDA Omada Health Inc. | New | 0.08% | +0.08 |
| ANGX Angel Studios Inc. | New | 0.01% | +0.01 |
| AEON Aeon Biopharma Inc. | Add +2.5% | 0.01% | +0.00 |
| BLNE Beeline Holdings Inc. | New | 0.00% | 0.00 |
| DELL Dell Technologies -C | Add +2.9% | 2.11% | −0.21 |
| CNDT Conduent Inc. | Add +8.2% | 2.88% | −1.02 |
Notes & Other Activity Q3 2025 → Q4 2025
| NIOBW Niocorp Developments Ltd. -28 | *W EXP 03/17/202 | Add +60.3% | 876,148 | $1.7M |
| DRTSW Alpha Tau Medical Ltd. -27 | *W EXP 99/99/999 | New | 1,166,118 | $396K |
| RZLVW Rezolve AI PLC -CW27 | *W EXP 08/15/202 | Reduce -1.2% | 289,309 | $240K |
| BNAIW Brand Engagement Netwo -CW27 | *W EXP 03/14/202 | Add +63.6% | 2,726,276 | $109K |
| LVWR.WS Livewire Group Inc.-27 | *W EXP 09/26/202 | Add +25.0% | 500,000 | $30K |
| BAERW Wildfire New Pubco Inc.-27 | *W EXP 01/24/202 | New | 25,000 | $5K |
| CEROW Phoenix Biotech Acq -CW26 | *W EXP 02/13/202 | Sold out | 224,930 | $3Kbefore exit |
| SDSTW Global Partner Acq A -CW27 | *W EXP 06/21/202 | Add +90.0% | 31,666 | $3K |
| PDYNW Sarcos Technology -CW27 | *W EXP 09/24/202 | New | 35,000 | $2K |
| CXAIW Kins Tech Group Class A -CW25 | *W EXP 99/99/999 | New | 12,500 | $625 |
| SLXNW Biomotion Sciences-CW29 | *W EXP 08/15/202 | New | 12,500 | $375 |
Bonds, preferreds, convertibles and warrants; not part of the stock holdings or percentages above.
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 48 | $656.7M | SPCX, AKTS, CGEM, LRMR, NCDL |
| Q1 2026 | 54 | $369.9M | AKTS, LRMR, ENGN, NCDL, CGEM |
| Q4 2025Amended | 50 | $320.9M | ENGN, NCDL, OBDC, LRMR, CGEM |
| Q3 2025 | 46 | $319.9M | NCDL, OBDC, ENGN, LRMR, EVCM |
| Q2 2025 | 46 | $308.2M | NCDL, OBDC, CGEM, EVCM, TRML |
| Q1 2025 | 45 | $309.2M | NCDL, OBDC, CGEM, EVCM, TRML |
| Q4 2024 | 48 | $432.6M | NCDL, KVYO, PLRX, OBDC, CGEM |
| Q3 2024 | 68 | $514.6M | NCDL, KVYO, TRML, PLRX, CGEM |
| Q2 2024 | 40 | $359.5M | CGEM, PLRX, OBDC, KVYO, LRMR |
| Q1 2024 | 44 | $500.6M | HOOD, CGEM, PLRX, ENGN, TRML |